Pharma-Bio Serv, Inc. Quarterly Depreciation, Depletion and Amortization in USD from Q2 2010 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Pharma-Bio Serv, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q2 2010 to Q4 2022.
  • Pharma-Bio Serv, Inc. Depreciation, Depletion and Amortization for the quarter ending January 31, 2023 was $16.1K, a 22.1% increase year-over-year.
  • Pharma-Bio Serv, Inc. Depreciation, Depletion and Amortization for the twelve months ending January 31, 2023 was $54K, a 16.2% decline year-over-year.
  • Pharma-Bio Serv, Inc. annual Depreciation, Depletion and Amortization for 2022 was $51.1K, a 29.7% decline from 2021.
  • Pharma-Bio Serv, Inc. annual Depreciation, Depletion and Amortization for 2021 was $72.7K, a 15.7% decline from 2020.
  • Pharma-Bio Serv, Inc. annual Depreciation, Depletion and Amortization for 2020 was $86.3K, a 12.9% decline from 2019.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $54K $16.1K +$2.92K +22.1% Nov 1, 2022 Jan 31, 2023 10-Q 2023-03-17
Q3 2022 $51.1K $12.8K -$1.49K -10.4% Aug 1, 2022 Oct 31, 2022 10-K 2023-01-30
Q2 2022 $52.6K $13K -$5.22K -28.7% May 1, 2022 Jul 31, 2022 10-Q 2022-09-14
Q1 2022 $57.8K $12.1K -$6.69K -35.5% Feb 1, 2022 Apr 30, 2022 10-Q 2022-06-14
Q4 2021 $64.5K $13.2K -$8.22K -38.4% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-17
Q3 2021 $72.7K $14.3K -$6.18K -30.2% Aug 1, 2021 Oct 31, 2021 10-K 2023-01-30
Q2 2021 $78.9K $18.2K -$5.02K -21.6% May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q1 2021 $83.9K $18.8K -$2.75K -12.7% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-14
Q4 2020 $86.7K $21.4K +$392 +1.86% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-17
Q3 2020 $86.3K $20.5K -$4.82K -19.1% Aug 1, 2020 Oct 31, 2020 10-K 2022-02-11
Q2 2020 $91.1K $23.2K -$1.92K -7.64% May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q1 2020 $93K $21.6K -$265 -1.21% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-14
Q4 2019 $93.3K $21K -$5.81K -21.6% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-17
Q3 2019 $99.1K $25.3K +$15.4K +156% Aug 1, 2019 Oct 31, 2019 10-K 2021-02-01
Q2 2019 $83.7K $25.1K +$4.64K +22.7% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q1 2019 $79K $21.8K +$630 +2.97% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-15
Q4 2018 $78.4K $26.8K +$3.8K +16.5% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-16
Q3 2018 $74.6K $9.86K +$201K Aug 1, 2018 Oct 31, 2018 10-K 2020-01-29
Q2 2018 -$126K $20.5K -$67.7K -76.8% May 1, 2018 Jul 31, 2018 10-Q 2019-09-16
Q1 2018 -$58.2K $21.2K -$79.4K -78.9% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-14
Q4 2017 $21.3K $23K -$86.4K -78.9% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-18
Q3 2017 $108K -$191K -$272K -334% Aug 1, 2017 Oct 31, 2017 10-K 2019-01-29
Q2 2017 $380K $88.2K +$10.6K +13.6% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 $369K $101K +$21.4K +27% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-14
Q4 2016 $348K $109K +$35.3K +47.6% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q3 2016 $313K $81.5K -$2.24K -2.67% Aug 1, 2016 Oct 31, 2016 10-K 2018-01-29
Q2 2016 $315K $77.7K -$12.4K -13.8% May 1, 2016 Jul 31, 2016 10-Q 2017-09-14
Q1 2016 $327K $79.2K -$13K -14.1% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-14
Q4 2015 $340K $74.1K -$17.2K -18.9% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-17
Q3 2015 $357K $83.7K -$12.1K -12.6% Aug 1, 2015 Oct 31, 2015 10-K 2017-01-31
Q2 2015 $370K $90.1K -$3.81K -4.06% May 1, 2015 Jul 31, 2015 10-Q 2016-09-14
Q1 2015 $373K $92.3K -$3.6K -3.75% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-14
Q4 2014 $377K $91.4K -$259 -0.28% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-16
Q3 2014 $377K $95.8K +$1.42K +1.5% Aug 1, 2014 Oct 31, 2014 10-K 2016-01-29
Q2 2014 $376K $93.9K +$7.85K +9.13% May 1, 2014 Jul 31, 2014 10-Q 2015-09-14
Q1 2014 $368K $95.9K +$12.8K +15.4% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-15
Q4 2013 $355K $91.7K +$10.6K +13% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 $345K $94.4K +$4.63K +5.15% Aug 1, 2013 Oct 31, 2013 10-K 2015-01-29
Q2 2013 $340K $86K +$5.76K +7.18% May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 $334K $83K +$7.62K +10.1% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-16
Q4 2012 $327K $81.1K +$4.79K +6.27% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 $322K $89.8K -$4.36K -4.63% Aug 1, 2012 Oct 31, 2012 10-K 2014-01-29
Q2 2012 $326K $80.3K +$2.37K +3.05% May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 $324K $75.4K +$1.28K +1.73% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 $322K $76.3K +$1.58K +2.12% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q3 2011 $321K $94.1K Aug 1, 2011 Oct 31, 2011 10-K 2013-01-29
Q2 2011 $77.9K -$1.63K -2.05% May 1, 2011 Jul 31, 2011 10-Q 2012-09-14
Q1 2011 $74.1K Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 $74.7K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q2 2010 $79.5K May 1, 2010 Jul 31, 2010 10-Q 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.